project id: TCGA-HNSC; case submitter id: TCGA-MT-A67D; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.93; rna integrity number: 7.6; age at index: 55; days to birth: -20386; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 20386; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage II; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 56.0; icd 10 code: C04.0; last known disease status: not reported; morphology: 8071/3; primary diagnosis: Squamous cell carcinoma, keratinizing, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior floor of mouth; synchronous malignancy: No; tissue or organ of origin: Anterior floor of mouth; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; creation datetime: 1366934400.0; is ffpe: false; composition: Not Reported; days to collection: 313; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-MT-A67D-01A-31; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 40.0; percent stromal cells: 0.0; percent tumor cells: 60.0; percent tumor nuclei: 65.0;